Hypertension, Portal
Showing 76 - 100 of 8,512
Program for TIPS and Follow Up Network 2 (NEPTUN2)
Recruiting
- Portal Hypertension
- TIPS procedure
-
Bonn, GermanyUniversity Hospital Bonn
Oct 4, 2021
Living Donor Liver Transplantation Trial (splenic artery ligation, No intervention)
Not yet recruiting
- Living Donor Liver Transplantation
- splenic artery ligation
- No intervention
- (no location specified)
Aug 14, 2021
Liver Diseases, Portal Hypertension Trial in Philadelphia (SHAPE measurement (Sonazoid ultrasoud contrast agent))
Completed
- Liver Diseases
- Portal Hypertension
- SHAPE measurement (Sonazoid ultrasoud contrast agent)
-
Philadelphia, Pennsylvania
- +1 more
Jul 20, 2021
Liver Cirrhosis, Portal Hypertension, Anticoagulant-induced Bleeding Trial in Xi'an (Heparin and Rivaroxaban)
Completed
- Liver Cirrhosis
- +3 more
- Heparin and Rivaroxaban
-
Xi'an, Shaanxi, Chinathe first hospital of xi'an jiaotong University
Aug 25, 2021
Hepatic Cirrhosis, Portal Hypertension Trial in Jinan (Endoscopic therapy+ beta blockers, Endoscopic therapy+ PSE+beta blockers,
Completed
- Hepatic Cirrhosis
- Portal Hypertension
- Endoscopic therapy+ beta blockers
- +6 more
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Sep 8, 2021
Portal Vein Thrombosis and Budd-Chiari Syndrome
Recruiting
- Hepatic Vein Thromboses
- +9 more
- Rotational thromboelastometry
- +2 more
-
Chandigarh, Choose Any State/Province, IndiaPostgraduate Institute of Medical Education and Research
Nov 5, 2021
Hypertension Trial in Glasgow (Kvatchii Portal)
Recruiting
- Hypertension
- Kvatchii Portal
-
Glasgow, Scotland, United KingdomGlasgow Clinical Research Facility
Jan 23, 2023
Hepatocellular Carcinoma, Cirrhosis, Portal Hypertension Trial in Cincinnati (Durvalumab, Tremelimumab, Liver Transplant)
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Durvalumab
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati
Dec 8, 2021
Portal Hypertension, Variceal Rebleeding Trial in China (Propranolol, Laparoscopic splenectomy and pericardial
Recruiting
- Portal Hypertension
- Variceal Rebleeding
- Propranolol
- +2 more
-
Beijing, Beijing, China
- +3 more
Aug 16, 2021
Portal Hypertension Trial in Chengdu (procedure, drug, device)
Completed
- Portal Hypertension
- 8mm-TIPS
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Nov 20, 2021
Hypertension, Cardiovascular Diseases Trial in Philadelphia (Texting, Online patient portal)
Completed
- Hypertension
- Cardiovascular Diseases
- Texting
- Online patient portal
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 10, 2022
HVPG and ICG-R15 in Short- and Medium-term Results of Surgery of
Recruiting
- Hepatocellular Carcinoma
- Hepatic venous-portal gradient (HVPG) measurement
-
Napoli, ItalyFederico II University Hospital
Mar 24, 2023
Portal Hypertension Trial in Vienna (Observational study)
Recruiting
- Portal Hypertension
- Observational study
-
Vienna, AustriaMedical University of Vienna
Aug 30, 2021
Portal Hypertension Trial in Chengdu (device, procedure, drug)
Recruiting
- Portal Hypertension
- 8mm-TIPS
- +2 more
-
Chengdu, ChinaWest china hospital
Nov 20, 2021
PVP on Clinical Outcomes in Patients With PH
Recruiting
- Portal Hypertension
- monitoring portal pressure gradient or hepatic venous pressure gradient
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Mar 26, 2021
Characterization and Pathogenesis of ACLF
Recruiting
- Liver Cirrhosis
- +2 more
-
Frankfurt, Hessen, GermanyTranslational Hepatology
Jul 23, 2021
Cirrhosis, Portal Hypertension Trial in Colmar, Strasbourg (Assessment of Minimal hepatic encephalopathy (MHE))
Recruiting
- Cirrhosis
- Portal Hypertension
- Assessment of Minimal hepatic encephalopathy (MHE)
-
Colmar, France
- +1 more
Apr 12, 2021
Hemodynamic Alterations in Liver Cirrhosis Validated by
Completed
- Portal Hypertension
- +3 more
-
Hvidovre, DenmarkCentre of Gastroenterology, Dept. of medicine. Hvidovre Universi
Aug 9, 2021
Cirrhosis, Portal Hypertension, Non-alcoholic Steatohepatitis Trial in Germany, Spain, United States (Emricasan, Placebo)
Hepatic Encephalopathy, Cirrhosis, Liver, Portal Hypertension Trial in Belgium, Netherlands (Rifaximin 550 milligram Oral Tablet
Recruiting
- Hepatic Encephalopathy
- +4 more
- Rifaximin 550 milligram Oral Tablet [XIFAXAN]
- +2 more
-
Leuven, Belgium
- +5 more
Feb 15, 2022
Portal Hypertension Trial in Kansas City (Transjugular Intrahepatic Portosystemic Shunt)
Completed
- Portal Hypertension
- Transjugular Intrahepatic Portosystemic Shunt
-
Kansas City, KansasUniversity of Kansas Medical Center
Sep 27, 2021
HVPG in Patients With Viral Cirrhosis
Not yet recruiting
- Portal Hypertension
- (no location specified)
Mar 11, 2021
The Clinical Significance of Portal Hypertension After Cardiac
Completed
- Surgery--Complications
- +4 more
- Doppler assessment of portal vein flow
-
Montreal, Quebec, CanadaMontreal Heart Institute
Feb 23, 2021
HCC, Cirrhosis, Liver Trial in Seoul (Liver CT)
Active, not recruiting
- HCC
- Cirrhosis, Liver
- Liver CT
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 16, 2021